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ABSTRACT
Objective: To assess the time to publication of
primary research and evidence syntheses funded by
the National Institute for Health Research (NIHR)
Health Technology Assessment (HTA) Programme
published as a monograph in Health Technology
Assessment and as a journal article in the wider
biomedical literature.
Study design: Retrospective cohort study.
Setting: Primary research and evidence synthesis
projects funded by the HTA Programme were included
in the cohort if they were registered in the NIHR
research programmes database and was planned to
submit the draft final report for publication in Health
Technology Assessment on or before 9 December 2011.
Main outcome measures: The median time to
publication and publication at 30 months in Health
Technology Assessment and in an external journal
were determined by searching the NIHR research
programmes database and HTA Programme website.
Results: Of 458 included projects, 184 (40.2%) were
primary research projects and 274 (59.8%) were
evidence syntheses. A total of 155 primary research
projects had a completion date; the median time to
publication was 23 months (26.5 and 35.5 months to
publish a monograph and to publish in an external
journal, respectively) and 69% were published within
30 months. The median time to publication of HTA-
funded trials (n=126) was 24 months and 67.5% were
published within 30 months. Among the evidence
syntheses with a protocol online date (n=223), the
median time to publication was 25.5 months
(28 months to publication as a monograph), but only
44.4% of evidence synthesis projects were published
in an external journal. 65% of evidence synthesis
studies had been published within 30.0 months.
Conclusions: Research funded by the HTA
Programme publishes promptly. The importance of
Health Technology Assessment was highlighted as the
median time to publication was 9 months shorter for a
monograph than an external journal article.
INTRODUCTION
In order for research to help patients and
aid clinicians in their decision-making it
must be published in full and made available
in a timely fashion. However, it is estimated
that over 50% of studies are never published
completely, and studies with disappointing
(non-signiﬁcant) results may not be pub-
lished at all.1 2 Non-publication is believed to
be primarily due to failure to write-up and
submit research, rather than manuscripts
being rejected.3 Studies with null or negative
ﬁndings take longer to be published than
those with positive results,4 5 and this publi-
cation bias may invalidate a meta-analysis,
leading to overestimation of treatment
effects. As a result, new interventions may be
adopted without suitable evidence to support
them.
During 2011/2012, the NIHR invested
£202.2 million in research across a broad
range of programmes and initiatives. Health
Technology Assessment (also known as the
monograph series) is the peer reviewed
journal for the NIHR HTA Programme.
Reports published in Health Technology
Assessment provide a full account of the
research project, including methods and a
full description of the results. These full
monographs complement shorter articles
submitted for publication in other peer-
reviewed journals, which the NIHR actively
encourages researchers to do as part of their
dissemination strategy.
Strengths and limitations of this study
▪ The study involves a large cohort, representing
almost 20 years of research funded on behalf of
the National Health Service.
▪ This report complements previous work which
has shown that 98% of Health Technology
Assessment projects funded since 2002 will
publish a monograph.
▪ This project relied heavily on the National
Institute for Health Research programmes data-
base and some data were not available for the
analyses.
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In addition to publication bias, selective outcome
reporting may also lead to overestimation of the effect-
iveness of the treatment, emphasising the need for rigor-
ous reporting of research. Trials funded by the NIHR
HTA Programme that only publish in Health Technology
Assessment tend to have a higher p value for the main
outcome compared with those that also have a publica-
tion in another journal. The full Health Technology
Assessment monograph generally contains more out-
comes than the main trial publication, and journal arti-
cles tend to report a higher proportion of statistically
signiﬁcant outcomes. Consequently, researchers includ-
ing HTA-funded trials in their systematic reviews are
recommended to use information from the monograph
and not from the associated journal article.6
Turner et al7 have shown that 98% of projects funded by
the HTA Programme in the past 10 years were published
in the monograph series. In contrast, Ross et al8 found that
only 68% of clinical trials funded by the US National
Institutes of Health (NIH) were published, with 46%
being published within 30.0 months of trial completion.
Tricco et al9 established that Cochrane reviews have a
median time to publication of 2.4 years (∼29.0 months),
but only 80.9% of Cochrane protocols are published
overall. Given the importance of publishing promptly and
the recommendation that researchers use data from the
monograph of a project, rather than from its journal
article; the aim of this study was to determine the time to
publication for HTA-funded primary research and evi-
dence synthesis projects in Health Technology Assessment and
biomedical literature, and to compare time to publication
with other organisations that fund or evaluate research.
METHODS
Cohort sample
The cohort in this project is derived from the NIHR
research programmes database. It is a subsample of the
dataset used by Turner et al7 and includes projects that
planned to submit their draft ﬁnal report on or before 9
December 2011 (as recorded in the NIHR research pro-
grammes database). Based on project classiﬁcation in the
database, the cohort was divided into two main categories:
primary research and evidence synthesis; primary research
was subdivided further into trials (as deﬁned by Ross
et al8) and the remainder were categorised as ‘others’.
Data extracted from the database included the project
reference number, its publication date in Health
Technology Assessment and the date when the evidence syn-
theses protocols were made available online. The Health
Technology Assessment monograph (or draft ﬁnal report or
external publication if the project did not have a pub-
lished monograph) was manually searched for the end
of recruitment date and length of follow-up in order to
calculate the study conclusion date for the primary
research projects. We also manually searched the Health
Technology Assessment journal website for the online publi-
cation date of the ﬁrst report for all projects in an
external journal. We took a pragmatic approach and
excluded protocols, background papers and systematic
reviews that may have been conducted before the
research began. We included the ﬁrst report that used
clinical data from the project, and excluded cost-
effectiveness analyses (unless the project report speciﬁc-
ally stated that it was an economic evaluation).
Time to publication
For primary research, the time to publication was deter-
mined by calculating the number of months from when
the study concluded (ie, end of follow-up, using the
same methodology as Ross et al8) to when the mono-
graph was ﬁrst published online and to when the ﬁrst
external publication was available online. For evidence
syntheses, we followed the protocol of Tricco et al.9 Time
to publication was measured as the number of months
from when the protocol was ﬁrst made available online
to the online publication date of the monograph and to
the online availability of the study in an external
journal.
Three researchers (FC, MA-K and JG) conducted data
extraction for the primary research dataset and any dis-
agreement was resolved in discussion. Two researchers
(FC and JG) extracted the data for the evidence synthe-
sis projects. Again, any disagreement was settled in dis-
cussion. In the case of primary research, the ﬁrst output
registered was often the protocol or a background
paper; consequently, two researchers (AY and FC) manu-
ally searched the HTA journal website to determine the
publication date of the ﬁrst report from a project and
this date was conﬁrmed in discussion.
Data analysis
Kaplan-Meier survival curves were produced for primary
research and evidence synthesis projects; the percentage
of HTA-funded studies published in the monograph
series was compared to other peer-reviewed journals. We
calculated the median (time for 50% of funded studies
to publish) time to publication in Health Technology
Assessment, elsewhere and for the ﬁrst output for primary
research, trials and evidence syntheses.
Ross et al8 have emphasised the need for timely publi-
cation and have stated a cut-off of 30 months for trials
funded by the NIH. We also calculated the percentage
of HTA-funded studies published at 30 months and the
total percentage published, both in the monograph
series and elsewhere.
Minitab was used to establish distribution of the data
subsets (Anderson-Darling normality test) and the IQR
were also determined. Any statistical difference between
the median times to publication was established using
the Mann-Whitney U test.
RESULTS
We identiﬁed 458 projects for inclusion in our analyses
(ﬁgure 1).
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Primary research
The primary research subset contains 184 projects;
however, 29 of these did not state an end of recruitment
date, or it was not possible to determine the length of
follow-up. Consequently, it was not possible to calculate
the last point of data collection for 15.8% of HTA
Programme-funded primary research, even though
many of these studies do have a publication.
Of the 155 primary research projects with a comple-
tion date, the median time to any publication (time for
50% of the funded studies to publish) was 23 months
(IQR 19.0 months) and 26.5 months (IQR 20.5 months)
for publication as a monograph in Health Technology
Assessment and 35.5 months (IQR 19.0 months) for publi-
cation in any other external journal, but this difference
was not statistically signiﬁcant (p=0.149).
Sixty-nine per cent of all primary research funded by
the HTA Programme is published within 30 months, but
only 56.1% of monographs are produced within this
time. Limiting the analysis to trials, directly comparable
to the work of Ross et al,8 67.5% were published within
30 months and have a median time to publication of
24 months (IQR 15.3 months; table 1). The overall publi-
cation rates are 92.9% for any publication, 88.4% in the
monograph and 62.6% in an external journal (table 1,
ﬁgure 2).
Evidence synthesis
Of the 274 evidence syntheses, the database did not
record a protocol online date for 51 (18.6%) projects
and so these could not be included in further analyses.
Of the remaining projects, the median time to any pub-
lication was 25.5 months (IQR 16 months) and the
median time to publication of a monograph is
28.0 months (IQR 19 months) but, unlike primary
research, fewer than 50% of evidence synthesis projects
were published in other peer-reviewed journals (table 2
and ﬁgure 3), so it was not possible to test for statistical
signiﬁcance. Evidence syntheses were published in a
timely fashion, with 65% of studies being published
within 30 months and 93.3% were published overall.
DISCUSSION
Using the standard of Ross et al,8 HTA-funded research
publishes promptly; 69% of primary research projects
were published within 30 months, with a median time to
publication of 23 months. Sixty-ﬁve per cent of evidence
synthesis projects were published within 30 months and
the median time to publication was 25.5 months.
Strengths and limitations
The main strength of this study is that it involves a large
cohort, representing almost 20 years of research funded
Figure 1 Flow diagram of
projects in this study.
Table 1 Publication characteristics of HTA Programme-funded primary research and trials (studies with a completion date)
Primary research (n=155) Trials (n=126)
Any publication HTA monograph External journal Any publication
Number of studies published (%) 144 (92.9%) 137 (88.4%) 97 (62.6%) 118 (93.7%)
Median time to publication (months) 23.0 26.5 35.5 24.0
Number of studies published at 30 months (%) 107 (69.0%) 87 (56.1%) 66 (42.6%) 85 (67.5%)
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on behalf of the National Health Service. This report
complements previous work which has shown that 98%
of HTA projects funded since 2002 will publish a mono-
graph.7 This project used a subsample of the dataset of
Turner et al7 with the intention to determine the time to
publication of all of the primary research and evidence
synthesis projects that do publish. However, a major limi-
tation of this project is the amount of data missing from
the analyses. It was not possible to determine the end of
follow-up for over 15% of primary research projects, and
over 18% of the evidence synthesis studies did not have a
recorded protocol online date, so they were not included
in the analyses. Since data-recording was poorer in
earlier years (unpublished data), we have disproportion-
ately excluded more of the older projects. Consequently,
since older projects generally took more time to publish
(unpublished data), we may be underestimating the time
HTA-funded studies take to publish overall.
This project relied heavily on data from the NIHR
research programmes database and the Health Technology
Assessment journal website to determine whether a study
has been published elsewhere, which in turn depends on
self-declarations from the PIs, as per contractual obliga-
tions. Preliminary work in an internal NETSCC report
found that the PIs were under-reporting their external
publications by 15.8% and so the overall external publica-
tion rate is likely to be higher and we are overestimating
the median time to publication in an external journal. In
addition, the under-reporting may also be affecting the
‘Any publication’ Kaplan-Meier curve and thereby inﬂu-
encing the median time to the ﬁrst publication as well.
Comparison with other studies
Ross et al8 highlighted the need for the publication
process to be prioritised in order to shorten the time
taken for research ﬁndings to be available to the public.
Their work found that the median time to publication
of clinical trials funded by the US NIH and registered
with ClinicalTrials.gov (and completed by 31 December
2008) was 23 months. However, this is only the median
of the trials that have been published, not the whole
cohort (ie, the trials that were funded) and so it is
underestimating the time to publication. Funders and
researchers should aspire to publish all of their research,
so the time taken for 50% of all funded studies to
publish is the appropriate median time to publication.
Arguably, the publication rate at 30 months may be the
truly important measure of timeliness to publication.
It takes ∼32 months for half of the clinical trials
funded by the US NIH to publish; only 46% were pub-
lished within 30 months of trial completion, with an
overall publication rate of 68%. In comparison, the
median time to publication of HTA Programme-funded
trials was 24 months, 67.5% being published within
Figure 2 Cumulative percentage of Health Technology
Assessment-funded primary research (studies with a study
completion date). Publication rate in the Health Technology
Assessment monograph versus other peer-reviewed
biomedical journals and time to the first publication anywhere.
Table 2 Publication characteristics of HTA Programme-funded evidence synthesis (studies with a protocol online date)
Evidence syntheses (n=223)
Any publication HTA monograph External journal
Number of studies published (%) 208 (93.3%) 207 (92.3%) 99 (44.4%)
Median time to publication (months) 25.5 28.0 –
Number of studies published at 30 months (%) 145 (65%) 122 (54.7%) 52 (23.3%)
Figure 3 Cumulative percentage of Health Technology
Assessment-funded evidence syntheses (studies with a
protocol online date). Publication rate in the Health
Technology Assessment monograph versus other
peer-reviewed biomedical journals and time to the first
publication anywhere.
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30 months, and 93.7% were published overall. The
Health Technology Assessment ﬁgures also compare very
favourably with the results from industry sponsored
trials; trials conducted by GlaxoSmithKline in Spain
between 2001 and 2006 had a publication rate of 61%
and a median time to publication of 28.4 months.
However, it was not clear whether this was the median of
the published trials or of the funded ones.10 The
median time to publication of more recent NIH clinical
trials (those with a ClinicalTrials.gov identiﬁer, published
during 2009 and indexed in MEDLINE) is 21 months,11
but the study did not comment on how long it took for
50% of the funded trials to publish. Finally, 68.0% of
NIH-funded studies were published overall and 62.6% of
HTA-funded primary research were published externally.
This highlights the importance of the monograph series
as it provides a means of publication for those projects
that would not otherwise reach the public domain.
HTA-funded evidence syntheses are also produced in
a timely manner, with a median time to publication of
25.5 months and 65% of studies being published within
30 months (93.3% publishing overall). In comparison,
Cochrane reviews have a median time to publication of
∼29 months, with only 80.9% publishing in full after
8 years of follow-up.
Implications
The median time to publication in the monograph series
and an external journal could only be compared for
primary research (as over half of the evidence syntheses
do not have a recorded external publication); here a
monograph is produced 9 months earlier. Publication
rate at 30 months and in total, for both types of research,
was considerably higher in the monograph series than
for other peer-reviewed biomedical journals. The shorter
time to publication and high publication rate in Health
Technology Assessment is laudable; ensuring information
from research is easily accessible and widely available is
important because it facilitates its use, increases its
impact and consequently its value to society.
Unpublished data may also invalidate the conclusions
from meta-analyses and systematic reviews. These are not
just a valuable source of information for healthcare pro-
fessionals and researchers, but deﬁnitive conclusions
about an intervention also prevent putting more patients
at risk in further unneeded trials or depriving them of
the correct treatment. Having Health Technology Assessment
is clearly important for dissemination of research to the
public in a timely fashion and to ensure that data are not
lost as a result of publication bias.
Conclusion and recommendations
Research funded by the HTA Programme is published in
a timely fashion; where a comparison was possible, time
to publication was 9 months shorter for a monograph
than an external journal article and publication rate was
considerably higher in Health Technology Assessment than
for other peer-reviewed journals, both overall and at
30 months. HTA-funded trials publish more promptly
than those funded by the NIH and industry and
HTA-funded evidence syntheses are produced sooner
than Cochrane reviews. This current study highlights the
importance of HTA Programme research being funded
via a contract that obliges researchers to publish their
ﬁndings in full.
Recommendations include encouraging other funding
organisations to make it a condition for their investiga-
tors to publish ﬁnal project results in full, within a set
time and to support this practice, regardless of whether
ﬁndings are signiﬁcant or not. In the UK, the Health
Research Authority (HRA) is responsible for protecting
and promoting the interests of patients and the public
in health research. It plays a key leadership role in pro-
moting transparency and has made a number of com-
mitments to ensure the publication and dissemination
of health research results.12
Future work should investigate the time to publication
for other funders and ways in which delays can be
reduced without compromising the quality. Regardless
of the funder, all trials should be registered and the
methods and results should be reported in full, as called
for by the AllTrials initiative,13 14 in a timely fashion.
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